While everyone talks global expansion, get the Brazil solution that actually works. Stop losing to competitors who "figured out Brazil" while you're still saying "it's too complex." The complete ecosystem that transforms Brazil from impossible into inevitable.
FREE Go-to-Market Report + Complete Regulatory Pathway
Exclusive MEDICA 2025 Offer · Limited to 50 Manufacturers
Brazil imports US$ 8B+ in medical devices annually because local production cannot meet demand for advanced technology. While you focus on saturated markets, Brazil offers the perfect storm of opportunity with 50% import dependency and higher margins than US and Europe when done right.
"We connect those who manufacture, with those who buy and those who deliver hospital products."
The only collaborative e-commerce platform connecting manufacturers directly to 7,000+ hospitals and GPOs. Bypass all intermediaries.
Every year at MEDICA, we hear the same three objections. Here's how we've solved each one.
Not another "platform" or "distributor." The only integrated system that owns the entire value chain from ANVISA to hospital delivery.
Thirty years of ANVISA expertise with 2,600+ products registered achieving a 94% approval rate across all medical device categories. BIHS hosts legal ownership with optional transfer after 24 months providing flexibility and risk mitigation. Complete end-to-end support from initial documentation to final approval and beyond including post-market surveillance and compliance management.
The only collaborative e-commerce platform connecting manufacturers directly to 7,000+ hospitals and GPOs bypassing all traditional intermediaries. Complete transparency with real-time tracking and compliance management. Expedited purchasing models reducing procurement time by 60%. National coverage across all 26 states plus Federal District ensuring comprehensive market access.
Brazil's largest certified distributor network with coverage in all 26 states plus Federal District ensuring 100% national distribution coverage. Network developed by medical specialty with deep market knowledge and established relationships. Collective investment funds plus equity participation enabling large-scale operations. Pre-vetted partners with transparent metrics and continuous qualified demand from GROPO platform.
Special tax regimes and trade facilitation leveraging Brazil's favorable tax programs for medical devices. Competitive pricing structure achieving 50%+ cost reduction on import costs through direct import models and bulk GPO structures. Strategic optimization of both import and sales taxes making your products competitively priced versus local market while maintaining healthy margins.
Upload your IFUs and commercial materials for personalized analysis. Everything you need to transform Brazil from "impossible" to "inevitable."
